Workflow
Sonoco(SON)
icon
Search documents
Sonoco (SON) Q3 Earnings Top Estimates
ZACKS· 2024-10-31 22:26
Sonoco (SON) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earnings of $1.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.47%. A quarter ago, it was expected that this packaging maker would post earnings of $1.26 per share when it actually produced earnings of $1.28, delivering a surprise of 1.59%.Over the last four quarters, the company has ...
Sonoco(SON) - 2024 Q3 - Quarterly Results
2024-10-31 20:24
October 31, 2024 Sonoco Reports Third Quarter 2024 Results Hartsville, S.C., U.S. - Sonoco Products Company ("Sonoco" or the "Company") (NYSE: SON), one of the largest sustainable global packaging companies, today reported financial results for its third quarter ended September 29, 2024. Summary: • Achieved GAAP net income attributable to Sonoco of $51 million, Adjusted EBITDA of $281 million, diluted earnings per share of $0.51 and Adjusted diluted earnings per share of $1.49 • Generated productivity impro ...
Sonoco Reports Third Quarter 2024 Results
GlobeNewswire News Room· 2024-10-31 20:07
HARTSVILLE, S.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), one of the largest sustainable global packaging companies, today reported financial results for its third quarter ended September 29, 2024. Summary: Achieved GAAP net income attributable to Sonoco of $51 million, Adjusted EBITDA of $281 million, diluted earnings per share of $0.51 and Adjusted diluted earnings per share of $1.49Generated productivity improvements of $39 million during the thi ...
Sonoco (SON) Earnings Expected to Grow: What to Know Ahead of Q3 Release
ZACKS· 2024-10-22 15:06
The market expects Sonoco (SON) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the ...
Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
GlobeNewswire News Room· 2024-10-09 12:45
Sonnet to receive $1.0 million in upfront payment and up to an additional $1.0 million in milestone payments with a royalty in the low double digits on net sales, less certain expenses, in the India market Alkem to fund, develop and commercialize SON-080 for the treatment of DPN in India and commercialize SON-080 for the treatment of Chemotherapy Induced Neuropathy (CIPN) and Autonomic Neuropathy in India The estimated market size of diabetic neuropathy in India was $120.3 million in 2023 and is expected to ...
SON vs. PKG: Which Stock Is the Better Value Option?
ZACKS· 2024-09-26 16:41
Investors interested in Containers - Paper and Packaging stocks are likely familiar with Sonoco (SON) and Packaging Corp. (PKG) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy that targets ...
Are Investors Undervaluing Sonoco (SON) Right Now?
ZACKS· 2024-09-26 14:46
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers. Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional va ...
Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors
GlobeNewswire News Room· 2024-09-18 12:30
SON-1010 is a targeted immune activation cancer therapy designed to turn 'cold' tumors 'hot' Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet") (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the completion of enrollment and initiation of dosing in its Phase 1 SB101 clinical trial of SON-1010 (IL12-FHAB) in adult patients with a ...
Sonoco Announces Pricing of $1.8 Billion of Senior Unsecured Notes
GlobeNewswire News Room· 2024-09-17 22:00
HARTSVILLE, S.C., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company ("Sonoco" or the "Company") (NYSE: SON), a global leader in high-value sustainable packaging, today announced that it has priced an offering (the "Offering") of senior unsecured notes in a combined aggregate principal amount of $1.8 billion (collectively, the "Notes"). The Notes will be issued in three tranches: $500 million in aggregate principal amount of 4.450% notes due 2026 $600 million in aggregate principal amount of 4.600% ...
SON or ATR: Which Is the Better Value Stock Right Now?
ZACKS· 2024-09-10 16:41
Investors interested in stocks from the Containers - Paper and Packaging sector have probably already heard of Sonoco (SON) and AptarGroup (ATR) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and ...